Human immunodeficiency virus (HIV) research has come a long way since the virus was discovered in the 1980s. Antiretroviral therapy (ART) marked a turning point in HIV treatment, changing the lives of ...

Roche's AXELIOS 1 enters next generation DNA sequencing. Can it or rivals unseat Illumina's long-standing market dominance?

Roohi Mariam Peter has been a journalist at Labiotech since 2023. She writes news articles and in-depth features on healthcare, biopharma, science, fundraising, markets, and emerging therapies. She ...

Europe’s pandemic preparedness capital is creating a rare opening for biotech innovators. Since COVID-19, the next pandemic is no longer abstract, and preparedness is no longer optional. Europe is ...

With 10 cases in 2025, Guinea worm could be the second disease ever eradicated. Here is what makes disease eradication ...

New therapies in the clinic for bipolar disorder hope to meet unmet needs of efficacy and minimal side effects.

June 2026 saw drug development in oncology and neurology continue and biotech deals over small molecules and RNA therapies ...

First, let’s take a look at the private biotech investments in June 2026, breaking them down by value, location, funding type, and therapeutic subsector. Last month, NewLimit was the company to raise ...

Novartis’ current strategy can be traced back to October 2023, when the Swiss pharma completed the spin-off of Sandoz, its generics and biosimilars business. The company described the move as the ...

Long renowned for its rich history, striking architecture, and thriving technology sector, Prague – and Czechia as a whole – is increasingly gaining recognition for something else: a fast-growing life ...

What readers will learn: Reduce manual effort through one automated, closed T cell manufacturing workflow, transferred across multiple sites with reproducible outcomes. Strengthen QC readiness through ...